Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Here are the top defense stock picks to watch. ... its stock has paid the price, dropping 54.13% despite a gain of nearly 37% in 2023. ... Defense stocks often pay solid dividends.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
The investment strategy focuses on dividend growth, selecting companies that have consistently increased dividend payments for at least a decade. Fund’s dividend yield: 1.7 percent
The Defence CBRN Centre is the home of the Joint CBRN Medical Faculty. The centre provides CBRN medical training to all medical officers in the UK Armed forces and courses are available to NATO/Allied Nations. As well as military training, Defence CBRN Centre also supports civilian response in partnership with the Health Protection Agency. [5]
Pages in category "Chemical, biological, radiological and nuclear defense" The following 11 pages are in this category, out of 11 total. This list may not reflect recent changes .
Science & Tech. Shopping. Sports
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]